Bei Akademie registrieren
Kusuri No Aoki stock, first-quarter results

Kusuri No Aoki stock holds focus after strong first-quarter growth

Published on 10/31/2026 at 01:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Kusuri No Aoki stock remains in focus after a strong first quarter. Management kept its full-year outlook unchanged for fiscal 2027.

Growth keeps investors focused

  • First-quarter sales increased 13.8 percent year over year, while net income attributable to owners rose 36.4 percent.
  • Kusuri No Aoki maintained its full-year earnings outlook for the fiscal year ending May 2027.
  • The chain is expanding its Food & Drug format, combining groceries, healthcare products and pharmacy services.
Kusuri No Aoki stock, first-quarter results, drugstore retail, Food & Drug, Japan equities, Illustration mit AI erstellt.
Kusuri No Aoki stock, first-quarter results, drugstore retail, Food & Drug, Japan equities, Illustration mit AI erstellt.

Kusuri No Aoki reported a sharp increase in first-quarter profit on October 1, 2026, as sales growth and the expansion of its store network supported results. A financial summary published by Japan IR said consolidated net sales reached 159.042 billion yen in the first quarter of the fiscal year ending May 2027.

Profit growth outpaced sales

Operating income rose 16.0 percent to 8.424 billion yen, while ordinary income increased 17.6 percent to 8.568 billion yen. Net income attributable to owners of the parent climbed 36.4 percent to 6.866 billion yen.

The company left its full-year forecast unchanged. It continues to target 640 billion yen in sales, 32 billion yen in operating income and 19 billion yen in net income for the year ending May 20, 2027. The unchanged outlook places attention on whether new stores, food sales and pharmacy services can sustain the current pace through the remaining quarters.

Food and pharmacies drive expansion

Kusuri No Aoki is pursuing a Food & Drug format that combines pharmaceuticals, cosmetics, daily necessities, groceries and in-store dispensing. Japan IR said the chain ended the quarter with 1,154 drugstores, while the company also continued opening stores and expanding pharmacy capacity.

A comparison published by kabutabi describes the group as a Hokuriku-based chain expanding into Tohoku, Kanto, Tokai, Kansai and Shikoku. It identifies Genky DrugStores and Tsuruha Holdings as direct competitors in overlapping markets, while Cosmos Pharmaceutical and Sundrug compete more broadly in food-focused and discount drugstore retail.

Business model and competition

Kusuri No Aoki Holdings operates drugstores, dispensing pharmacies and supermarkets in Japan, with headquarters in Hakusan, Ishikawa Prefecture. Its model emphasizes one-stop shopping, fresh food and prescription services alongside traditional health and beauty products. Relative to regional competitor Kawachi Pharmaceutical, the kabutabi comparison portrays Kusuri No Aoki as the faster-growing chain, while Genky DrugStores and Tsuruha Holdings represent more direct competition in food-focused and overlapping regional markets.

Kusuri No Aoki Holdings

  • Company: Kusuri No Aoki Holdings Co., Ltd.
  • Ticker: 3549.T
  • Quarter: First quarter of the fiscal year ending May 2027
  • Net sales: 159.042 billion yen, up 13.8 percent year over year
  • Operating income: 8.424 billion yen, up 16.0 percent
  • Net income: 6.866 billion yen, up 36.4 percent
  • Full-year outlook: Unchanged
Disclaimer...
en | boerse | 70437312 |